Home Cart Sign in  
Chemical Structure| 1361227-90-8 Chemical Structure| 1361227-90-8

Structure of JH-RE-06
CAS No.: 1361227-90-8

Chemical Structure| 1361227-90-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

JH-RE-06 is an effective REV1-REV7 interaction inhibitor (IC50 = 0.78 μM; Kd = 0.42 μM), targeting the interaction of REV7 with the POLζ subunit REV1.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of JH-RE-06

CAS No. :1361227-90-8
Formula : C20H16Cl3N3O4
M.W : 468.72
SMILES Code : O=C1C(C(CC(C)C)=O)=C(NC2=C(Cl)C=C(Cl)C=C2)NC3=C(Cl)C=CC(N(=O)=O)=C31
MDL No. :MFCD32197217

Safety of JH-RE-06

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of JH-RE-06

DNA

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HCC1937 2.5 μM 3 hours JH-RE-06 treatment leads to accumulation of ssDNA gaps in BRCA1-deficient HCC1937 cells PMC8500949
UWB1.289 1.5 μM JH-RE-06 shows preferential toxicity towards BRCA1-deficient UWB1.289 cells PMC8500949
SKOV3 cells 1.5 μM 24 hours Assessed SA-β-Gal activity, Caspase 3/7 activation levels, p21 expression levels, and cell survival rates PMC6644000
MEFs cells 1.5 μM 24 hours Assessed SA-β-Gal activity, Caspase 3/7 activation levels, p21 expression levels, and cell survival rates PMC6644000
A375 cells 1.5 μM 24 hours Assessed SA-β-Gal activity, Caspase 3/7 activation levels, p21 expression levels, and cell survival rates PMC6644000
HT1080 cells 1.5 μM 24 hours Assessed SA-β-Gal activity, Caspase 3/7 activation levels, p21 expression levels, and cell survival rates PMC6644000
Wild-type HFs 1.5 µM 24 hours Evaluated the effect of JH-RE-06 on TLS frequency, finding that JH-RE-06 significantly reduced TLS frequency, similar to the effect of Rev1 knockdown. PMC8415319

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c-nu mice Subcutaneous transplantation tumor model Intraperitoneal injection 1.6 mg/kg Twice a week until the tumor volume reached approximately 100 mm3 To verify the enhancing effect of JH-RE-06 on radiosensitivity of lung cancer in vivo PMC11131313
BALB/c nude mice Xenograft Mice model Intratumoral injection 1.6 mg/kg Every other day JH-RE-06 significantly inhibited the growth of xenograft tumors, reduced tumor size and weight, and significantly prolonged the survival time of tumor-bearing mice PMC8814179

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.13mL

0.43mL

0.21mL

10.67mL

2.13mL

1.07mL

21.33mL

4.27mL

2.13mL

 

Historical Records

Categories